Skip to main content

Peer Review reports

From: Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial

Original Submission
3 Sep 2023 Submitted Original manuscript
11 Oct 2023 Reviewed Reviewer Report
26 Dec 2023 Reviewed Reviewer Report
13 Jan 2024 Reviewed Reviewer Report
17 Jan 2024 Reviewed Reviewer Report
24 Jan 2024 Author responded Author comments - Rahim Badrfam
Resubmission - Version 2
24 Jan 2024 Submitted Manuscript version 2
25 Jan 2024 Reviewed Reviewer Report
16 Feb 2024 Author responded Author comments - Rahim Badrfam
Resubmission - Version 3
16 Feb 2024 Submitted Manuscript version 3
Publishing
20 Feb 2024 Editorially accepted
26 Feb 2024 Article published 10.1186/s12888-024-05627-0

You can find further information about peer review here.

Back to article page